Could a single drug treat the two leading causes of death in the US: cancer and cardiovascular disease?

Cardiovascular disease and cancer seem to be quite different on the surface. It turns out that tiny, engineered nanoparticles that can target specific immune cells may be a way to treat both cancer and cardiovascular disease. Atherosclerosis is the most deadly form of cardiovascular disease.